You are logged in as Log out

Prooxidant Control of Cancer

by Randolph Howes, M.D., PhD

Digitally identify and quantitate prooxidant food sources for ingestion that will produce a state of “oxidative bliss,” such that we can protect against and control cancer.

Kentwood, LA Cancer

Share this project and help them win!


All Team Company Patients MedEd Physicians Mission Supporters

About this project

The problem we solve:
Each day, some 1,600 people die of cancer in the United States. That number goes up 10-fold, up to 21,000 if you include the global population. My research has found 34 cancerous cell types that are killed in the laboratory by prooxidants. Many of these same malignant cell types are protected or shielded from an apoptotic death by antioxidants. By creating a condition of "oxidative bliss", we will increase our ability to not only kill cancer cells but will also offer additional levels of protection from getting cancer in the first place. Additionally, such a move would increase our immunity and our ability to kill pathogenic bacteria, fungi, protozoans and lipid coated viruses. My extensive research backs up this premise. The reason for the failed war against cancer stems from a flawed theoretical paradigm that categorized cancer as an exclusively “free radical disease.” My approach lends the potential to treat all types of cancer.
About our solution:
My approach lends the potential to treat all types of cancer because it exploits the one weakness that is common to every cancer cell: an electronically modified oxygen derivative (EMOD, ROS) insufficiency. Cancer cells exhibit persistent oxidative stress, which is insufficient to cause cellular death. This altered homeostasis renders cancer cells vulnerable to exogenous oxidizing agents that generate additional EMODs (ROS), which are likely to increase oxidative stress levels above the cytotoxic, death threshold. Altered metabolism, together with activated oncogenic signaling and deregulation of mitochondrial function, typically results in an increase in the generation of reactive oxygen species (ROS, EMODs) in cancer cells. Interestingly, this phenomenon leads to a differential redox homeostasis in normal and malignant cells that is gaining ground as a promising target for the design of more selective and effective anticancer agents, without injuring normal cells.
Progress to date: I have formulated a proprietary blend supplement to suppress already established cancer and it will help prevent new cases from becoming victims of this current pandemic.

About Our Team


Dr. Randolph Howes, M.D., PhD
Plastic Surgery , Practicing Physician
Medical school: Tulane School of Medicine
Bio: Raised on a small bucolic strawberry farm in Ponchatoula, Louisiana, Dr. Randolph Howes learned ethics, morality, hard work and respect for his fellow man at a young age. Humble beginnings launched his lifetime trek of achievement as a scientist, surgeon, scholar, visionary, philanthropist, international lecturer, singer, songwriter, business entrepreneur, broadcaster, inventor, author, newspaper columnist, corporate executive and rancher. In 1961, Dr. Howes entered Southeastern Louisi
Title: Prof.

About Our Company

US Medical Scientific Research Foundation, Inc.
Location: Kentwood, Louisiana
Website: http://www.iwillfindthecure.org
Product stage: idea
Sales: Working on it
Employees: 1-2

How We Help Patients

Differential redox homeostasis in normal and malignant cells suggests that pro-oxidant-induced upregulation of cellular reactive oxygen species (ROS, EMODs) should selectively target cancer cells without compromising the viability of untransformed, normal cells. Consequently, a pro-oxidant deviation well-tolerated by nonmalignant cells might rapidly reach a cell-death threshold in malignant cells already at a high setpoint for constitutive EMOD stress or EMOD mediated apoptosis (cancer cell death). Prooxidative (EMOD) therapies are compatible with chemotherapy, radiation therapy and surgery. There is no reason to avoid it because it will only complement other forms of cancer treatment. Please remember that chemotherapy and radiation therapy can wipe out your immune system, speed up cancer’s spread and destroy your oxidative ability to kill cancer. Thus, you must be willing to boost or restore your EMODs to a point of “oxidative bliss.” Let’s hear it for “oxygen to the rescue.

How We Help Education

Nixon declared war on cancer in 1971. So why, after forty years, billions of dollars, and thousands of biochemists and researchers devoting their careers to solving the mysteries of cancer, have we made shamefully few inroads? Cancer is a global scourge and is far from being controlled. However, decades of my research has exposed the fact that electronically modified oxygen derivatives (EMODs) are a major factor leading to cellular suicide (apoptosis) for cancerous cells, across a wide spectrum of human cell types. Physicians must be educated on the benefits of redox chemistry, especially in the fight against cancer.

How We Help Physicians

Finally, we can offer a new, innovative means to decrease the risk of developing cancer.

Challenge Mission

Mission: I have found that over 34 cell types of human cancer are killed by EMOD induced apoptosis. Most amazingly, prooxidant EMODs selectively kill cancer cells and do not harm normal cells.
Use of funds: I need assistance with secretarial help, since I have to do everything myself.
Intellectual Property Status: My proprietary blend supplemental formulation to suppress and protect against cancer is totally my intellectual property.
FDA Status: My supplemental blend is not a drug and is not subject to FDA medicine regulation.
Personal Message: Cancer is a global scourge and is far from being controlled. However, decades of my research has exposed the fact that electronically modified oxygen derivatives (EMODs) are a major factor leading to cellular suicide (apoptosis) for cancerous cells, across a wide spectrum of human cell types. In fact, I have found that over 34 cell types of human cancer are killed by EMOD induced apoptosis. Most amazingly, prooxidant EMODs selectively kill cancer cells and do not harm normal cells.

Supporters

  • image
    05/21/2016 Nancy Gephart - Nurse

    Liked the project.

  • image
    05/21/2016 Nancy Gephart - Nurse

    Followed the project.

  • image
    05/20/2016 Linda Phillips - Other

    Followed the project.

  • image
    05/20/2016 Linda Phillips - Other

    Liked the project.

3

likes

3

Follows

0

Pilots

0

Partners

48

Interest
Score

1

Adoption
Score


Randolph Howes, M.D., PhD
Physician
Prof.
Tulane School of Medicine

See Full Proflle
Contact Us